CSSPF

Healthcare Medical Devices

NIOX Group Plc

$0.90

-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap

378.32M

Avg Volume

P/E (TTM)

44.95

EPS

$0.02

52W High

$0.92

52W Low

$0.75

Div. Yield

1.8%

Valuation

P/B Ratio

4.31

P/S Ratio

7.96

EV/EBITDA

25.40

EV/Revenue

7.59

Margins

Gross Margin 69.5%

Operating Margin 22.9%

Net Margin 14.7%

EBITDA Margin 29.9%

Growth & Returns

Revenue Growth (YoY)

(4.8%)

Earnings Growth (YoY)

(0.7%)

Earnings Growth (QoQ)

0.0%

Return on Equity

10.7%

Return on Assets

9.0%

Liquidity & Leverage

Current Ratio

4.60

Quick Ratio

3.32

Debt / Equity

0.01

Total Cash

16.80M

Total Debt

700,000

About

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.